PATENT CLAIM ANALYSIS

Application Number: 15989464
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-04
Patent Classification: ["424", "185100"]

Abstract:
Provided are methods for inducing and maintaining protective immunity against a tumor expressing FRα in a subject, comprising the administration of one or more peptide vaccines according to a particular dosages or particular dosage regimens.

Claim (Index 17):
A method of inducing and maintaining an immune response to a tumor expressing FR\u03b1 in a subject, the method comprising,\n (a) administering a first vaccine comprising between about 0.1 and about 2 mg of a peptide consisting of the amino acid sequence of SEQ ID NO:1 (E39) and an adjuvant every three to four weeks for a period of about two to about six months; \n (b) subsequently administering a second vaccine comprising between about 0.1 and about 2 mg of a peptide consisting of the amino acid sequence of SEQ ID NO: 2 (E39\u2032) and an adjuvant every three to four weeks for a period of about two to six months; and \n (c) administering a booster composition comprising between about 0.1 and about 2 mg of a peptide consisting of an amino acid selected from the group consisting of SEQ ID NO: 1 and SEQ ID NO: 2, and an adjuvant about six months after step (b).

Metadata:
- Claim Count in Document: 50.0
- Percentile: 93.0
- Lexical Diversity: 1.12121
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15169328', '14327224', '12602214', '13534550', '13133487']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7325707151200703
- 35 USC 102 Novelty (BERT): 0.6940598021801779
- Combined Prediction Score: 0.7287196238260811
- Mean Citation Score: 496.55999800000006
- Max Citation Score: 714.1568599999997
- Similarity Product: 698.1944656695674

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test